Insider and Congress filings

Cigna Corporation (CI)

Healthcare Plans, listed on NYSE.

S&P 500338 insider transactions137 Congress tradeslast filed Oct 7, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Nov 5, 2026

Cigna beat by 6.1% on adjusted EPS.

$7.98 a share against a $7.52 consensus. Revenue $73.7B against $72.6B, in line.

EPS

Reported$7.98
Consensus$7.52

Revenue

Reported$73.7B
Consensus$72.6B

Beat 5In line 1

Next report Feb 4, 2027. Consensus $7.19 a share.

Every quarter

Money managers13F filings for Jun 30, 2026

4

of the 97 fund managers GetSignal tracks list Cigna among their largest positions. Two Sigma held the most, $499.8M.

Every manager

Insider tradesForm 4 · 5 open-market filings shown

Five open-market sales, 4 of them under 10b5‑1 plans.

May 12, 2026Sep 3, 2026

SalesSales under a plan

4 of 5 under a plan

A median 2 business days from trade to filing. Form 4 is due within two.

Every filing
Companyfrom the company's filings and listing, as of Nov 14, 2026

About Cigna Corporation

Exchange
NYSE
Sector
Healthcare
Industry
Medical - Healthcare Plans
Chief executive
Brian C. Evanko
Employees
66,685
Listed since
Mar 31, 1982
Market value
$78.3B
Price to earnings (12 mo)
13.1
Net income per share, as reported (12 mo)
$22.79
Dividend yield
2.08%

www.thecignagroup.com

Earnings6 reported quarters · next on Feb 4, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Nov 5, 2026$7.98$7.52$73.7B$72.6BEPS beatRevenue in line
Q2 FY2026reported Jul 30, 2026$7.78$7.60$71.7B$70.1BEPS beatRevenue beat
Q1 FY2026reported Apr 30, 2026$7.79$7.60$68.5B$66.3BEPS beatRevenue beat
Q4 FY2025reported Feb 5, 2026$8.08$7.88$72.5B$70.3BEPS beatRevenue beat
Q3 FY2025reported Oct 30, 2025$7.83$7.64$69.7B$67.6BEPS beatRevenue beat
Q2 FY2025reported Jul 31, 2025$7.20$7.16$67.2B$62.9BEPS in lineRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

No earnings call briefs on CI yet. Briefs from every company we cover.

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on CI, newest first
FirmRatingTargetActionDate
Wells FargoEqual Weightrated Jul 31, 2026$325Raised from $307
BernsteinOutperform$390Raised from $387
Piper SandlerOverweight$370Target set
JefferiesHold$307Target set
Raymond JamesOutperform$320Target set
BairdNot stated$362Raised from $337
GuggenheimBuy$361Target set
Wolfe ResearchNot stated$315Target set
MizuhoOutperform$340Raised from $330
BarclaysEqual Weight$304Target set
UBSBuy$400Raised from $375
Morgan StanleyOverweight$361Raised from $355
Deutsche BankHold$302Target set
Cantor FitzgeraldOverweight$340Target set
Truist SecuritiesBuy$350Raised from $320
TD CowenBuy$338Raised from $333

Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.

1 other firm rated CI in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 16, 2026.

Proxy statementas filed for fiscal 2025 · proxy filed Mar 13, 2026

Executive pay

David M. Cordani’s pay as CEO came to $22.9M for fiscal 2025.
ExecutiveSalaryStock awardsOtherTotal
David M. CordaniChair and Chief Executive Officer$1.6M$13.9M$7.3M$22.9M
Brian C. EvankoPresident and Chief Operating Officer$1.1M$5.1M$3.9M$10.0M
Nicole S. JonesExecutive Vice President, Chief Administrative Officer, and General Counsel$893K$2.9M$2.1M$6.0M
Ann M. DennisonExecutive Vice President, Chief Financial Officer, The Cigna Group$773K$2.3M$1.6M$4.7M
Everett NevilleExecutive Vice President, Strategy and Business Development$800K$1.7M$1.6M$4.1M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

13F filings13F positions as of Sep 30, 2026

Institutional holders

1,394 institutions reported Cigna shares in 13F filings for Sep 30, 2026.
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$6.6B24,113,368+2.9%9.14%
Vanguard Capital Management LLC$4.7B17,290,980+0.1%6.55%
State Street Corp$3.5B12,959,550+2.2%4.91%
Dodge & Cox$3.3B12,255,467+0.7%4.64%
Sanders Capital, LLC$2.7B10,098,076-0.5%3.83%
Massachusetts Financial Services Co$2.7B9,740,280-6.7%3.69%
FMR LLC$1.9B6,813,015-15.0%2.58%
Geode Capital Management, LLC$1.8B6,817,241+8.8%2.58%
Vanguard Portfolio Management LLC$1.7B6,307,222+1.3%2.39%
JPMorgan Chase & Co.$1.4B5,051,747-2.7%1.91%
Morgan Stanley$1.0B3,745,005+1.5%1.42%
Arrowstreet Capital, Limited Partnership$757.4M2,786,463-2.2%1.06%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Sep 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

13F filings4 managers

Tracked fund managers holding CI

ManagerValueSharesShare of book
Two Sigma$499.8M1,813,1100.4%
Glenview CapitalLarry Robbins$113.6M412,2232.1%
Leon CoopermanOmega Advisors$89.6M325,0002.5%
David EinhornGreenlight Capital$24.4M88,4000.6%

4 of the 97 fund managers we track list CI shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.

Form 45 filings shown · newest filing first

Open-market insider trades

InsiderActionSharesPriceValueTrade dateDelay
(business days)
Everett NevilleSold · scheduled617$284.05$175KSep 3, 2026filed Sep 8, 20262d
Nicole S. JonesSold · scheduled2,677$279.61$749KAug 18, 2026filed Aug 20, 20262d
Nicole S. JonesSold · scheduled19,436$276.27$5.4MAug 4, 2026filed Aug 6, 20262d
Jamie G. KatesChief Accounting OfficerSold899$298.61$268KJun 12, 2026filed Jun 16, 20262d
David CordaniChairman & CEOSold · scheduled · 13 lines201,878$292.82$59.1MMay 12, 2026filed May 14, 20262d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Brian C. EvankoStock award9,829Sep 1, 2026
George KurianDirectorStock award109Aug 31, 2026
Bryan HolgersonStock award0.887Jul 9, 2026
Bryan HolgersonStock award0.946Jul 23, 2026
Bryan HolgersonStock award0.984Aug 6, 2026
Nicole S. JonesOption exercise1,301Aug 5, 2026
Nicole S. JonesOption exercise14,045Aug 4, 2026
Matthew PerlbergOther Form 4 entry (see filing)6,343Mar 1, 2026
Matthew PerlbergOther Form 4 entry (see filing)5,658Mar 1, 2025
Matthew PerlbergOther Form 4 entry (see filing)791Mar 1, 2023
Matthew PerlbergOther Form 4 entry (see filing)3,136Mar 1, 2024
Jason D. SadlerOther Form 4 entry (see filing)5,791Mar 1, 2026
Jason D. SadlerOther Form 4 entry (see filing)6,257Mar 1, 2024
Jason D. SadlerOther Form 4 entry (see filing)5,400Mar 1, 2025
Adam KautznerOther Form 4 entry (see filing)8,708Mar 1, 2026
Adam KautznerOther Form 4 entry (see filing)5,955Mar 1, 2025
Adam KautznerOther Form 4 entry (see filing)3,764Mar 1, 2024
Adam KautznerOther Form 4 entry (see filing)1,778Mar 1, 2023
Adam KautznerOther Form 4 entry (see filing)2,008Mar 1, 2022
Adam KautznerOther Form 4 entry (see filing)1,579Feb 26, 2021

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

STOCK Act20 disclosures of 137 on record · median 27d of the 45 allowed

Congress trades in CI

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Ro KhannaStockSale$1,001 - $15,000+9.2% since the saleEstimated exit price $272.01, close on Fri Sep 25Current price $297.00, close on Fri Nov 13Sep 25, 2026Oct 7, 202612d
Ro KhannaStockSale$1,001 - $15,000+4.6% since the saleEstimated exit price $283.94, close on Mon Jul 20Current price $297.00, close on Fri Nov 13Jul 20, 2026Aug 7, 202618d
Julie JohnsonJointFiled lateStockSale$1,001 - $15,000+2.4% since the saleEstimated exit price $290.08, close on Tue Sep 23, 2025Current price $297.00, close on Fri Nov 13Sep 23, 2025Aug 5, 2026316d
Julie JohnsonJointFiled lateStockPurchase$1,001 - $15,000+2.4% since the tradeEstimated entry price $290.08, close on Tue Sep 23, 2025Current price $297.00, close on Fri Nov 13Sep 23, 2025Aug 5, 2026316d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000+13.4% since the tradeEstimated entry price $261.96, close on Fri Mar 27Current price $297.00, close on Fri Nov 13Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockSale$15,001 - $50,000+8.9% since the saleEstimated exit price $272.72, close on Tue Jun 2Current price $297.00, close on Fri Nov 13Jun 2, 2026Jul 6, 202634d
Ro KhannaStockPurchase$1,001 - $15,000+4.1% since the tradeEstimated entry price $285.27, close on Fri May 15Current price $297.00, close on Fri Nov 13May 15, 2026Jun 9, 202625d
Ro KhannaStockSale$1,001 - $15,000+7.7% since the saleEstimated exit price $275.64, close on Fri Apr 24Current price $297.00, close on Fri Nov 13Apr 24, 2026May 11, 202617d
Ro KhannaStockSale$15,001 - $50,000+8.0% since the saleEstimated exit price $275.12, close on Mon Apr 13Current price $297.00, close on Fri Nov 13Apr 13, 2026May 11, 202628d
Jared MoskowitzDependent childStockSale$1,001 - $15,000+13.6% since the saleEstimated exit price $261.49, close on Mon Mar 23Current price $297.00, close on Fri Nov 13Mar 23, 2026Apr 30, 202638d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+11.2% since the saleEstimated exit price $267.19, close on Fri Mar 13Current price $297.00, close on Fri Nov 13Mar 13, 2026Apr 7, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+2.2% since the tradeEstimated entry price $290.71, close on Tue Feb 17Current price $297.00, close on Fri Nov 13Feb 17, 2026Mar 9, 202620d
Ro KhannaStockPurchase$1,001 - $15,000+5.7% since the tradeEstimated entry price $281.00, close on Tue Feb 24Current price $297.00, close on Fri Nov 13Feb 24, 2026Mar 9, 202613d
Ro KhannaStockPurchase$1,001 - $15,000+9.3% since the tradeEstimated entry price $271.81, close on Tue Jan 13Current price $297.00, close on Fri Nov 13Jan 13, 2026Feb 6, 202624d
Ro KhannaStockPurchase$15,001 - $50,000+9.5% since the tradeEstimated entry price $271.27, close on Thu Jan 29Current price $297.00, close on Fri Nov 13Jan 29, 2026Feb 6, 20268d
Julie JohnsonJointStockSale$1,001 - $15,000+8.4% since the saleEstimated exit price $274.00, close on Thu Dec 18, 2025Current price $297.00, close on Fri Nov 13Dec 18, 2025Jan 15, 202628d
Julia LetlowFiled lateStockPurchase$1,001 - $15,000-6.5% since the tradeEstimated entry price $317.57, close on Wed Oct 23, 2024Current price $297.00, close on Fri Nov 13Oct 23, 2024Jan 13, 2026447d
Julia LetlowFiled lateStockSale$1,001 - $15,000-11.9% since the saleEstimated exit price $337.07, close on Tue Apr 22, 2025Current price $297.00, close on Fri Nov 13Apr 22, 2025Jan 13, 2026266d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+9.2% since the tradeEstimated entry price $271.89, close on Fri Dec 19, 2025Current price $297.00, close on Fri Nov 13Dec 19, 2025Jan 12, 202624d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000+9.8% since the saleEstimated exit price $270.61, close on Wed Nov 12, 2025Current price $297.00, close on Fri Nov 13Nov 12, 2025Dec 15, 202533d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in CI filterable by party, chamber, type and account.

STOCK Act6 members · estimate, as of Nov 14, 2026

Members of Congress reporting a position

6 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
J. French HillRepublican · House$50,001 - $100,0000.5%
Lucy McBathDemocrat · House$50,001 - $100,0000.8%
Mark HarrisRepublican · House$15,001 - $50,0001.3%
Robert BresnahanRepublican · House$15,001 - $50,0000.1%
Donald NorcrossDemocrat · House$1,001 - $15,0007.3%
Robert B. AderholtRepublican · House$1,001 - $15,0001.0%

The largest estimated position is in the $50,001 - $100,000 band. Estimate, as of Nov 14, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 16, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on CI show and how current they are.

Are insiders buying or selling CI?

Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 4 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded CI?

Ro Khanna, Julie Johnson, Alan Armstrong, Jared Moskowitz, Gilbert Ray Cisneros, Jr. and Julia Letlow disclosed CI transactions in the filings shown here.

Which members of Congress hold CI?

6 members of Congress report a position in CI in the estimate we hold as of Nov 14, 2026. The two largest estimated positions belong to J. French Hill and Lucy McBath; Mark Harris holds one of the next largest, in the $15,001 - $50,000 band. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is CI in the S&P 500 or the Nasdaq 100?

Cigna Corporation is a current member of the S&P 500, per the membership list we hold as of Nov 16, 2026. Current members of either index get a page here whatever their filing history.

How quickly are CI trades disclosed?

Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track